Patient P-02464

Synthetic patientMETA-24 · Day 164 · 25–34 · F · baseline S18Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Deteriorating

GI state

Improving

Inflammatory state

Deteriorating

Nutritional resilience

Favorable

Discontinuation risk

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S18
Day 25 ME-01 recommended — Monitoring Escalation ME-01
Day 26 Patient accepted — Started ME-01 in the companion
Day 29 Deterioration detected before clinical escalation — Monitoring Escalation ME-01

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Inflammatory activity+9
Toxicity+9
GI instability-7
Nutritional resilience+3
Treatment adherence+3

What helped?

Monitoring Escalation ME-01Day 25
Result: deterioration detected before clinical escalation

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

58 min

stable · -0.3 vs previous 14 d

Sleep duration

Wearable

7.5 h

stable · +0.2 vs previous 14 d

Energy level

Daily log

6.4/10

stable · -0.2 vs previous 14 d

Steps

Wearable

5,477

worsening · -413 vs previous 14 d

GI burden

Companion

8.7/100

improving · -0.9 vs previous 14 d

Adherence

Companion

93.2 %

stable · +0.2 vs previous 14 d

Sleep quality

Wearable

63.5/100

improving · +3.1 vs previous 14 d

Glucose, CGM daily mean

CGM

127 mg/dL

stable · +1.4 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 85 from the failing basin, 14 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -4.6 next day on high-intake days · n 22

Would not help

Nothing clearly counter-productive in the record.

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-4.6supporter · 95%
Ultra-processed food
-1no signal · 25%
Simple carbohydrates
+0.9no signal · 22%
Dietary fat load
+0.6no signal · 15%
Histamine load
-0.4no signal · 15%
Insoluble fibre
+0.3no signal · 15%
Caffeine
-0.3no signal · 15%
Alcohol
-0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 3 · butyrate capacity 58/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 71 ms
Sleep: 7.8 h
Steps: 4,879
Resting HR: 72 bpm

Daily log: GI score 9, nutritional resilience 72, adherence 93.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02486	43%	S10	ME-01	improved	86
P-02127	42%	S11	SC-12	improved	73
P-02630	41%	S17	NP-02	improved	76
P-02667	38%	S08	HY-01	improved	77
P-02277	37%	S05	AD-05	improved	92
P-02690	37%	S02	ME-01	improved	73
P-02193	36%	S11	CR-01	improved	87
P-02450	36%	S12	NP-02	improved	92
P-02068	35%	S14	NP-02	improved	83
P-02441	35%	S11	SC-12	improved	67
P-02249	34%	S09	DT-01	improved	100
P-02415	34%	S17	GI-04	improved	86